126 related articles for article (PubMed ID: 2392594)
1. [Determination of antibodies against Borrelia burgdorferi in patients with morphea, lichen sclerosus et atrophicus and erythema chronicum migrans].
Pinazo Canales I; Betlloch Mas I; Mestre Bauza F; Salva Armengod F; Parras Vázquez F; Alomar Cardell J
Rev Clin Esp; 1990 Apr; 186(7):320-3. PubMed ID: 2392594
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
3. [Anti-Borrelia burgdorferi antibodies in chronic erythema migrans, benign lymphadenosis cutis, scleroderma and scleroatrophic lichen].
Afa G; Caprilli F; Crescimbeni E; Morrone A; Prignano G; Fazio M
G Ital Dermatol Venereol; 1990 Sep; 125(9):369-73. PubMed ID: 2079346
[TBL] [Abstract][Full Text] [Related]
4. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
6. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
Ranki A; Aavik E; Peterson P; Schauman K; Nurmilaakso P
J Invest Dermatol; 1994 Mar; 102(3):339-45. PubMed ID: 8120417
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
9. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients.
Fujiwara H; Fujiwara K; Hashimoto K; Mehregan AH; Schaumburg-Lever G; Lange R; Schempp C; Gollnick H
Arch Dermatol; 1997 Jan; 133(1):41-4. PubMed ID: 9006371
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606
[TBL] [Abstract][Full Text] [Related]
11. Evidence for spirochetal origin of circumscribed scleroderma (morphea).
Aberer E; Stanek G; Ertl M; Neumann R
Acta Derm Venereol; 1987; 67(3):225-31. PubMed ID: 2442935
[TBL] [Abstract][Full Text] [Related]
12. [Borrelia burgdorferi antibodies in scleroderma circumscripta, lichen sclerosus et atrophicus, erythema nodosum, granuloma annulare, erythema annulare and chronic urticaria].
Svecova D; Buchvald J
Bratisl Lek Listy; 2000; 101(4):194-9. PubMed ID: 10914463
[TBL] [Abstract][Full Text] [Related]
13. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review.
Alonso-Llamazares J; Persing DH; Anda P; Gibson LE; Rutledge BJ; Iglesias L
Acta Derm Venereol; 1997 Jul; 77(4):299-304. PubMed ID: 9228224
[TBL] [Abstract][Full Text] [Related]
14. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.
Dillon WI; Saed GM; Fivenson DP
J Am Acad Dermatol; 1995 Oct; 33(4):617-20. PubMed ID: 7673495
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification.
Schempp C; Bocklage H; Lange R; Kölmel HW; Orfanos CE; Gollnick H
J Invest Dermatol; 1993 May; 100(5):717-20. PubMed ID: 8491994
[TBL] [Abstract][Full Text] [Related]
16. [Serodiagnosis in dermatological diseases in Borrelia burgdorferi infections].
Hofmann H; Meyer-König U
Hautarzt; 1990 Aug; 41(8):424-31. PubMed ID: 2272826
[TBL] [Abstract][Full Text] [Related]
17. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
[TBL] [Abstract][Full Text] [Related]
18. [Borrelia burgdorferi, clinical aspects, cultivation and identification of the pathogen in erythema migrans in Berlin].
Ott A; Schönberg A
Z Hautkr; 1989 Aug; 64(8):644-8. PubMed ID: 2678789
[TBL] [Abstract][Full Text] [Related]
19. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus.
Ross SA; Sánchez JL; Taboas JO
Am J Dermatopathol; 1990 Aug; 12(4):357-62. PubMed ID: 2393064
[TBL] [Abstract][Full Text] [Related]
20. [The clinical and serological manifestations of Lyme disease in Russia].
Anan'eva LP; Skripnikova IA; Barskova VG; Steere AC
Ter Arkh; 1995; 67(11):38-42. PubMed ID: 8571249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
